All
Acne therapy: How far have we really come?
October 1st 2009Acne therapy is and has always been an important part of every dermatology practice. Whether we are accustomed to treating infantile acne, teenage acne, adult acne or even the Aesthetic complications of acne, therapy for acne is a complicated issue.
2010 tax increases: Protect your wealth now; avoid greater liability next year
October 1st 2009All signs lead to future tax increases. We have historic deficit levels, an aggressive legislative agenda and a president whose campaign promises included raising taxes on households with annual incomes above $250,000.
Conservative investing: Certificates of deposit offer stability, protection in turbulent times
October 1st 2009If you're of a conservative bent, you probably have some of your savings invested in bank certificates of deposit (CDs). If so, you're already well aware of the poor rates that CDs are paying these days.
Going too far? Derms question pediatric warning for TN
October 1st 2009Although hardly unexpected, the Food and Drug Administration's decision to add a warning about a possible link between tumor necrosis factor (TNF) antagonists and cancer in children goes too far, say most dermatologists contacted by Dermatology Times.
Examining Dr. Mohs: With no formal residency training, doctor devised revolutionary technique
October 1st 2009The treatise on the "Evolution of Mohs" written by your senior staff correspondent John Jesitus and published in your July 2009 issue contains a very significant error. Frederick Mohs' professional life was not "general surgery's loss," for Dr. Mohs never was a surgeon (nor a dermatologist). I was informed he "completed an internship - most likely of the rotating kind - and then started his research and practice."
Treating diversity: Patients of color have unique cosmetic concerns
October 1st 2009New York - Patients of color have a unique set of skin concerns, and those concerns need to be addressed while clinicians are treating patients, according to Andrew Alexis, M.D., M.P.H., a dermatologist at St. Luke?s-Roosevelt Hospital in New York.
Researching morphea: UV-A1 phototherapy recommended for darker-skinned patients
October 1st 2009World report - Darker-skinned patients with morphea and related diseases are as likely to benefit from ultraviolet (UV) light therapy as patients with lighter skin. Some clinicians had speculated that the increased level of melanin found in darker skin might impede UV-A1, but that does not appear to be the case.